These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Streptomyces olivaceus 142. II. Isolation of the antibiotic and its properties. Mordarski M, Wieczorek J, Szyba K. Arch Immunol Ther Exp (Warsz); 1969; 17(5):639-48. PubMed ID: 5370182 [No Abstract] [Full Text] [Related]
15. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. Iwatsuki M, Uchida R, Yoshijima H, Ui H, Shiomi K, Matsumoto A, Takahashi Y, Abe A, Tomoda H, Omura S. J Antibiot (Tokyo); 2008 Apr; 61(4):222-9. PubMed ID: 18503201 [Abstract] [Full Text] [Related]
16. [Conditions for formation and isolation of valinomycin--a regulator of cell membrane permeability]. Smirnova GM, Blinova IN, Koloditskaia TA, Khokhlov AS. Antibiotiki; 1970 May; 15(5):387-92. PubMed ID: 5429606 [No Abstract] [Full Text] [Related]
17. [Characterization of a resistoflavin-producing streptomyces strain as well as isolation and properties of the new antibiotic]. Bradler G, Eckardt K. Z Allg Mikrobiol; 1972 May; 12(7):537-47. PubMed ID: 4663502 [No Abstract] [Full Text] [Related]
18. Novel fermentation procedures for the production and the isolation of antibiotics. Uri JV. Acta Microbiol Hung; 1986 May; 33(4):305-10. PubMed ID: 3630627 [Abstract] [Full Text] [Related]
19. [Parallel variability of the producers of the antibiotic heliomycin, Actinomyces olivocinereus and Actinomyces variabilis]. Vinogradova KA, Vasil'eva LS. Mikrobiologiia; 1974 May; 43(6):1084-9. PubMed ID: 4449495 [No Abstract] [Full Text] [Related]
20. Monensin, a new biologically active compound. II. Fermentation studies. Stark WM, Knox NG, Westhead JE. Antimicrob Agents Chemother (Bethesda); 1967 May; 7():353-8. PubMed ID: 5596159 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]